Pathologic findings in pregnancies with unexplained increases in midtrimester maternal serum human chorionic gonadotropin levels

American Journal of Clinical Pathology

Volumn 111, Issue 2, 1999, Pages 209-215

  Liu, Dong Feng ^a   Dickerman, Lois H ^a   Redline, Raymond W ^a  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Human chorionic gonadotropin; Placenta; Preeclampsia; Triple test

Indexed keywords

CHORIONIC GONADOTROPIN;

ARTICLE; CHROMOSOME ABERRATION; DISEASE ASSOCIATION; FEMALE; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL SERUM; MORPHOMETRICS; PLACENTA DISORDER; PREECLAMPSIA; PREGNANCY COMPLICATION; PREMATURE LABOR; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SCREENING TEST; SECOND TRIMESTER PREGNANCY;

EID: 0344889203     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/111.2.209     Document Type: Article

References (40)

1. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosomal abnormalities. Prenat Diagn. 1987;7:623-630.
2. Haddow JE, Palomaki GE, Knight JG, et al. Prenatal screening for Down's syndrome with use of maternal serum markers. N Engl J Med. 1992;327:588-593.
3. Gonen R, Perez R, David M, et al. The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications. Obstet Gynecol. 1992;80:83-86.
4. Gravett CP, Buckmaster JG, Watson PT, et al. Elevated second trimester maternal serum beta hCG concentrations and subsequent adverse pregnancy outcome. Am J Med Genet. 1992;44:485-486.
5. Wenstrom KD, Owen J, Boots LB, et al. Elevated second-trimester human chorionic gonadotropin levels in association with poor pregnancy outcome. Am J Obstet Gynecol. 1994;171:1038-1041.
6. Kuller JA, Sellati LE, Chescheir NC, et al. Outcome of pregnancies with elevation of both maternal serum alpha-fetoprotein and human chorionic gonadotropin. Am J Perinatol. 1995;93-97.
7. Jauniaux E, Gulbis B, Tunkel S, et al. Maternal serum testing for alpha-fetoprotein and human chorionic gonadotropin in high-risk pregnancies. Prenat Diagn. 1996;16:1129-1135.
8. Beekhuis JR, Van Lith JMM, De Wolf BTHM, et al. Increased maternal serum alpha-fetoprotein and human chorionic gonadotropin in compromised pregnancies other than for neural tube defects or Down syndrome. Prenat Diagn. 1992;12:643-647.
9. Morssink LP, de Wolf BTHM, Kornman LH, et al. The relation between serum markers in the second trimester and placental pathology: a study on extremely small for gestational age fetuses. Br J Obstet Gynaecol. 1996;103:779-783.
10. Lee IS, Chung DYK, Cole LA, et al. Elevated serum nicked and urinary beta-core fragment hCG in preeclamptic pregnancies. Obstet Gynecol. 1997;90:889-892.
11. Muller F, Aegerter P, Boue A. Prospective maternal serum human chorionic gonadotropin screening for the risk of fetal chromosome anomalies and of subsequent fetal and neonatal deaths. Prenat Diagn. 1993;13;29-43.
12. Morssink LP, Sikkema-Raddatz B, Beekhuis JR, et al. Placental mosaicism is associated with unexplained second-trimester elevation of MShCG levels, but not with elevation of MSAFP levels. Prenat Diagn. 1996;16:845-851.
13. Tantravhi U, Matsumoto C, Delach J, et al. Trisomy 16 mosaicism in amniotic fluid cell cultures. Prenat Diagn. 1996;16:749-754.
14. Driscoll SG, Langston C. College of American Pathologists Conference XIX on the Examination of the Placenta: report on the Working Group on Methods for Placental Examination. Arch Pathol Lab Med. 1991;115:704-708.
15. Aherne WA, Dunnill MS. Quantitative aspects of placental structure. J Pathol Bacteriol. 1966;91:123-139.
16. Aherne WA, Dunnill MS. Morphometry. London, England: Arnold; 1982:1-44.
17. Naeye RL. Do placental weights have clinical significance? Hum Pathol. 1987;18:387-391.
18. Redline RW, Patterson P. Patterns of placental injury: correlations with gestational age, placental weight, and clinical diagnosis. Arch Pathol Lab Med. 1994;118:698-701.
19. Benirschke K, Kaufmann P. Normative values and tables. In: Pathology of the Human Placenta. 3rd ed. New York, NY: Springer-Verlag; 1994:41-48.
20. Redline RW. The placenta. In: Stefaneanu L, Kovacs K, eds. Molecular and Cellular Endocrine Pathology. London, England: Chapman and Hall; In press.
21. Vaitukaitis JL, Braunstein GD, Ross GT. A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. Am J Obstet Gynecol. 1972;113:751-758.
22. Daily CA, Laurent SL, Nunley WC. The prognostic value of serum progesterone and quantitative β-human chorionic gonadotropin in early human pregnancy. Am J Obstet Gynecol. 1994;171:380-384.
23. Muller F, Savey L, Lefiblec B, et al. Maternal serum human chorionic gonadotropin level at fifteen weeks is a predictor for preeclampsia. Am J Obstet Gynecol. 1996;175:37-40.
24. McDonald TW, Ruffolo EH. Modern management of gestational trophoblastic disease. Obstet Gynecol Surv. 1983;38:67-83.
25. Dar H, Merksamer R, Berdichevsky D, et al. Maternal serum markers levels in consecutive pregnancies: a possible genetic predisposition to abnormal levels. Am J Med Genet. 1996;61:154-157.
26. O'Brien JE, Dvorin E, Drugan A, et al. Race-ethnicity-specific variation in multiple-marker biochemical screening: alpha fetoprotein, hCG, and estriol. Obstet Gynecol. 1997;89:355-358.
27. Heikinheimo M, Seppala M. Amniotic fluid human chorionic gonadotropin in late pregnancy: elevated levels in toxemia with intrauterine growth retardation. Am J Obstet Gynecol. 1983;146:766-768.
28. Sorenson TK, Williams MA, Zhingheim RW, et al. Elevated second trimester human chorionic gonadotropin and subsequent pregnancy induced hypertension. Am J Obstet Gynecol. 1993;169:834-838.
29. Morssink LP, Kornman LH, Beekhuis JR, et al. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: relation to fetal weight and preterm delivery. Prenat Diagn. 1995;15:1041-1046.
30. Lee IS, Chung DYK, Cole LA, et al. Elevated serum nicked and urinary beta-core fragment hCG in preeclamptic pregnancies. Obstet Gynecol. 1997;90:889-892.
31. Ashour AMN, Lieberman ES, Haug LEW, et al. The value of elevated second-trimester beta-human chorionic gonadotropin in predicting development of preeclampsia. Am J Obstet Gynecol. 1997;176:438-442.
32. Jauniaux E, Gulbis B, Tunkel S, et al. Maternal serum testing for alpha fetoprotein and human chorionic gonadotropin in high risk pregnancies. Prenat Diagn. 1996;16:1129-1135.
33. Barker DJP, Bull AR, Osmond C, et al. Fetal and placental size and risk of hypertension in adult life. BMJ. 1990;301:259-262.
34. Barker DJP. Intrauterine programming of coronary heart disease and stroke. Acta Paediatr. 1997;423:178-182.
35. Redline RW, Patterson P. Preeclampsia is associated with an excess of proliferative immature intermediate trophoblast. Hum Pathol. 1995;26:594-600.
36. Redman CWG. Current topic: pre-eclampsia and the placenta. Placenta. 1991;12:301-308.
37. Fox H. Pathology of the placenta. In: Histologic Abnormalities of the Placenta. Philadelphia, Pa: Saunders; 1978:149-197.
38. Genbacev O, Zhou Y, Ludlow JW, et al. Regulation of human placental development by oxygen tension. Science. 1997;277:1669-1672.
39. Newby D, Aitken DA, Crossley JA, et al. Biochemical markers of trisomy 21 and the pathophysiology of Down's syndrome pregnancies. Prenat Diagn. 1997;17:941-951.
40. Petraglia F, Florio P, Nappi C, et al. Peptide signaling in human placenta and membranes: autocrine, paracrine, and endocrine mechanisms. Endocr Rev. 1996;17:156-185.